Objectives: The objective of the study was to determine the frequency of Acute Kidney Injury (AKI) in patients treated with intravenous acyclovir for presumed viral infections. Study Design: Cross-sectional study. Place and Duration of Study: Department of Pediatric Medicine, NICH, Karachi, Pakistan for 6 months from January 1, 2021 to June 30, 2021. Material and Methods: This study comprises of children aged 6 months to twelve years who received intravenous acyclovir for presumed viral infections from January-June 2021. Patients with known kidney diseases were excluded. Patients were diagnosed as AKI by applying pediatric Risk, Injury, Failure, Loss, and End-stage Kidney (pRIFLE) criteria. Demographic and clinical data was collected and analyzed using descriptive statistics. Results: Among 100 patients, 62 were males. The mean age was 5.75 ± 4.39 years. The primary diagnosis was presumed viral meningoencephalitis (57%), encephalitis (29%), and meningitis (14%). The AKI was diagnosed in 11% of children on acyclovir. Sixty-four patients were admitted in Pediatric Intensive Care (p 0.004) for ventilatory support (p 0.000) and 73% received inotropes (p0.002). AKI -patients received lower maintenance fluid compared to non-AKI (109.33 ± 34.35 vs. 140.91 ± 30.15; p0.004). Contributing factors for AKI were PICU admission, ventilatory and inotrope support, nephrotoxic agents use and lower maintenance fluid. Conclusion: We found AKI in 11% of cases treated with acyclovir. PICU admission, inotropic and ventilation, nephrotoxic drugs and inadequate hydration were important contributing factors. Adequate hydration, avoiding nephrotoxic drugs and monitoring renal function may decrease AKI.